drugset / Trial / NCT02544919

Lipids and Neurological Complications in Liver Transplantation

NCT02544919

Phase 4 Unknown 80 enrolled Mansoura University
RandomizedParallel-groupSingle-blindPrevention

Summary

To study the impact of pretreatment of living donor liver transplantation recipients with SMOF lipid on the incidence and severity of post-transplantation neurological complications in patients receiving tacrolimus based immunosuppression protocol

Timeline

Start
2015-09
Primary completion
2017-09
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator SMOFlipid Other / unclassified 1 g/kg Intravenous

Indications

No indication recorded.